OrthoPediatrics Q1 2020 Earnings Report
Key Takeaways
OrthoPediatrics Corp. announced its financial results for the first quarter ended March 31, 2020, reporting a total revenue of $16.4 million, up 11.6% from $14.7 million in the first quarter of 2019. The company saw strong domestic revenue growth of 30.4% and continued to advance its strategic initiatives, including the acquisition of ApiFix and the launch of new products.
Total revenue for first quarter 2020 was $16.4 million, up 11.6% from first quarter 2019.
Domestic revenue growth was 30.4% for the first quarter 2020.
Acquired ApiFix and MID-C system on April 1st, expanding portfolio of novel technologies to treat scoliosis.
Expanded the domestic sales organization to 167 consultants, up 21.0% from first quarter 2019.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Forward Guidance
Due to the rapidly evolving environment and continued uncertainties surrounding the duration and impact of COVID-19, OrthoPediatrics maintains suspension of its revenue growth and set consignment guidance for the full year 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income